HIGHLIGHTS
- •We investigated which cognitive domains are affected by anxiety in a twelve year follow-up cohort study.
- •Anxiety symptoms were associated with a decline of verbal memory in older adults and with poorer performance in non-amnestic domains in women.
- •Adequate treatment of anxiety symptoms could potentially beneficially influence the risk for developing neurodegenerative disease.
Objective
Methods
Results
Conclusion
Key Words
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of Geriatric PsychiatryReferences
- Anxiety as a predictor for cognitive decline and dementia: a review and meta-analysis.Am J Geriatr Psychiatry. 2016; 24: 823-842
- O'Hara R: Late-life anxiety and cognitive impairment: a review. Am J Geriatr Psychiatry. 2008; 16: 790-803
Gulpers B, Lugtenburg A, Zuidersma M, Verhey FRJ, Voshaar RCO. Anxiety disorders and figural fluency: a measure of executive function. J Affect Disord 2018;234:38--44.
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.Lancet Neurol. 2013; 12: 357-367
- Depression, anxiety and cognition in community-dwelling adults aged 70 years and over.J Psychiatr Res. 2012; 46: 1662-1666
- Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: a review.Gerontology. 2000; 46: 163-177
- Cognitive impairment: dementia and Alzheimer's disease.Annu Rev Public Health. 1992; 13: 431-449
- Cognitive reserve in ageing and Alzheimer's disease.Lancet Neurol. 2012; 11: 1006-1012
- Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences.Clin Epidemiol. 2014; 6: 37-48
- Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis.Am J Psychiatry. 2015; 172: 323-334
- Comorbid anxiety disorder in late life depression: association with memory decline over four years.Int J Geriatr Psychiatry. 2005; 20: 848-854
Jolles J, Houx PJ, van Boxtel MPJ, et al: The Maastricht Aging Study: determinants of cognitive aging. (online). Available at: breinweb.nl/maas/assets/maas_pb_intro.pdf. Accessed October 22, 2018
- Computerized health information in the Netherlands: a registration network of family practices.Br J Gen Pract. 1992; 42: 102-106
- SCL-90. Een Multidimensionale Psychopathologie Indicator (SCL-90. A Multidimensional Psychopathology Indicator).Swets Test Publishers, Lisse, Netherlands1986
- The Concept Shifting Test: adult normative data.Psychol Assess. 2006; 18: 424-432
- A new version of the Trail-Making Test as an information processing task.J Clin Neuropsychol. 1985; 7: 162
- Age-related decline of psychomotor speed: effects of age, brain health, sex, and education.Percept Mot Skills. 1993; 76: 195-211
- The Stroop color-word test: influence of age, sex, and education; and normative data for a large sample across the adult age range.Assessment. 2006; 13: 62-79
- Learning and retrieval rate of words presented auditory and visually.J Gen Psychol. 1985; 112: 201-210
- Rey's verbal learning test: normative data for 1855 healthy participants aged 24–81 years and the influence of age, sex, education, and mode of presentation.J Int Neuropsychol Soc. 2005; 11: 290-302
- The Letter Digit Substitution Test: normative data for 1,858 healthy participants aged 24-81 from the Maastricht Aging Study (MAAS): influence of age, education, and sex.J Clin Exp Neuropsychol. 2006; 28: 998-1009
- Handleiding Groninger Intelligentietest (GIT) (Manual Groningen Intelligence Test [GIT]).Swets & Zeitlinger Publishers, Lisse, Netherlands1983
- Effect sizes for growth-modeling analysis for controlled clinical trials in the same metric as for classical analysis.Psychol Methods. 2009; 14: 43-53
- A regression framework for effect size assessments in longitudinal modeling of group differences.Rev Gen Psychol. 2013; 17: 111-121
- Anxiety is not associated with the risk of dementia or cognitive decline: the Rotterdam Study.Am J Geriatr Psychiatry. 2014; 22: 1382-1390
- Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study.Br J Psychiatry. 2014; 204: 400-401
- Neuropsychiatric symptoms in older people with and without cognitive impairment.J Alzheimers Dis. 2012; 31: 411-420
- Anxiety symptoms and risk of cognitive decline in older community-dwelling men.Int Psychogeriatr. 2017; 29: 1137-1145
- Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.JAMA Psychiatry. 2015; 72: 284-291
- Mild worry symptoms predict decline in learning and memory in healthy older adults: a 2-year prospective cohort study.Am J Geriatr Psychiatry. 2012; 20: 266-275
- Phobic anxiety and cognitive performance over 4 years among community-dwelling older women in the Nurses' Health Study.Am J Geriatr Psychiatry. 2013; 21: 1125-1134
- Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.Arch Gen Psychiatry. 2005; 62: 593-602
- Chronicity, relapse, and illness—course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up.Depress Anxiety. 2003; 17: 173-179
- Predictors of change in anxiety symptoms of older persons: results from the Longitudinal Aging Study Amsterdam.Psychol Med. 2000; 30: 515-527
- Psychological and somatic symptoms of anxiety and risk of coronary heart disease: the health and social support prospective cohort study.Biol Psychiatry. 2010; 67: 378-385
- The neuropsychological profile of vascular cognitive impairment not demented: a meta-analysis.J Neuropsychol. 2015; 9: 109-136
- Alzheimer's disease.N Engl J Med. 2004; 351: 56-67
- Depression, anxiety and cognition in community-dwelling adults aged 70 years and over.J Psychiatr Res. 2012; 46: 1662-1666
- Predictors of progression from mild cognitive impairment to Alzheimer disease.Neurology. 2007; 68: 1596-1602
- Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder.Psychoneuroendocrinology. 2008; 33: 773-781
- Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.Arch Gen Psychiatry. 2000; 57: 925-935
- Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states.Neurosci Biobehav Rev. 2003; 27: 233-246
- Stress hormones and human memory function across the lifespan.Psychoneuroendocrinology. 2005; 30: 225-242
- Prospective study of anxiety and incident stroke.Stroke. 2014; 45: 438-443
- Neuroinflammatory pathways in anxiety, posttraumatic stress, and obsessive compulsive disorders.Psychiatry Res. 2015; 229: 37-48
- Cytokine-associated emotional and cognitive disturbances in humans.Arch Gen Psychiatry. 2001; 58: 445-452
- Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.Biomark Med. 2010; 4: 871-887
- Longitudinal cognitive outcomes of clinical phenotypes of late-life depression.Am J Geriatr Psychiatry. 2017; 25: 1123-1134
- The association between depression, anxiety, and cognitive function in the elderly general population—the Hordaland Health Study.Int J Geriatr Psychiatry. 2005; 20: 989-997
- The association of anxiety and depression with future dementia diagnosis: a case-control study in primary care.Fam Pract. 2013; 30: 25-30
- Anxiety, depression, and 1-year incident cognitive impairment in community-dwelling older adults.J Am Geriatr Soc. 2011; 59: 1421-1428
- The factor structure of SCL-90 and MCMI scale scores: within-measure and interbattery analyses.Multivariate Behav Res. 1992; 27: 1-20